top of page
gradient banner_home page.png

Contact us

Dzuveo Logo Whiteout.png

Find out more...

Get in touch with us to find out more about how our Dzuveo® sublingual sufentanil 30 mcg tablet can support you in providing excellent patient care. 

 

An Aguettant team member will follow up with you shortly to provide additional information. 

3 steps to Dzuveo® 
sublingual sufentanil tablets

01

Watch our 'How to' Dzuveo® video to see just how easy it is to use - making it ideal for many different clinical settings including emergency and trauma, post-operative pain, and painful procedures.

02

Sign up for our emails to receive the latest news about Dzuveo®, including updates on new clinical data, support tools and product availability.

03

Request an appointment with an Aguettant Key Account Manager to discuss how Dzuveo® can help you and your patients better control pain.

Safe administration

Dzuveo® is to be administered by a healthcare professional in a medically monitored setting only. A medically monitored setting must have equipment and personnel trained to detect and manage hypoventilation, and availability of supplemental oxygen and opioid antagonists, such as naloxone. Dzuveo® should only be prescribed and administered by healthcare professionals who are experienced in the management of opioid therapy; particularly opioid adverse reactions, such as respiratory depression

bottom of page